Metraipolis › archive › dc_925cbe2ef5aa

Radiolabeling and evaluation of 64+67Cu-2,2'-(1,2,4-Oxadiazole-3,5-diyl)di aniline as a theranostic agent for solid tumors — Europe PMC PMID:41145684

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41145684
DOI
10.1038/s41598-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-11-09T00:44:21.198Z
SHA-256 of the archived text
2938c9e29f321eda277d236dfa1d5bd658bbbe005dd0d2c0822b5dd6eb175286
Stable URL of this page
https://metraipolis.com/documento/dc_925cbe2ef5aa

How to cite

Radiolabeling and evaluation of 64+67Cu-2,2'-(1,2,4-Oxadiazole-3,5-diyl)di aniline as a theranostic agent for solid tumors — Europe PMC PMID:41145684 — Europe PMC (en), https://europepmc.org/article/MED/41145684 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_925cbe2ef5aa (Metraipolis archive dc_925cbe2ef5aa, sha256 2938c9e29f321eda277d236dfa1d5bd658bbbe005dd0d2c0822b5dd6eb175286)
BibTeX
@misc{dc925cbe2ef5aa,
  title = {Radiolabeling and evaluation of 64+67Cu-2,2'-(1,2,4-Oxadiazole-3,5-diyl)di aniline as a theranostic agent for solid tumors — Europe PMC PMID:41145684},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41145684},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_925cbe2ef5aa; sha256 2938c9e29f321eda277d236dfa1d5bd658bbbe005dd0d2c0822b5dd6eb175286},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41145684. Agents can read the archived copy with the MCP tool read_document.